Boston | October 18, 2025 — The premium health-related domain VeraMed.com has been sold for $167,500, marking one of the more notable brand-driven acquisitions in the medical and healthcare digital space this year. The transaction underscores the continuing demand for short, professional .com names that resonate with both investors and end-users.
A Strong Brand Match
The buyer of VeraMed.com has not been publicly disclosed, but the domain’s attributes suggest it could be an ideal fit for a healthcare startup, pharmaceutical firm, or digital health platform. The name combines “Vera” (derived from the Latin word for truth) with “Med” (a universal abbreviation for medicine), producing a brand that conveys trust, authenticity, and medical expertise.
Industry analysts note that such qualities are highly valued in healthcare, where credibility and patient confidence are central to adoption. “Names like VeraMed.com can serve as instant trust-builders,” one broker commented, “and that’s a priceless advantage in the health-tech market.”
Why the Price Matters
At $167,500, VeraMed.com sits comfortably in the mid-six-figure range, a level typically reserved for domains with strong brandability and clear industry relevance. While far from record-breaking, the sale is significant because:
- Healthcare is a high-growth sector: With global spending on digital health and telemedicine accelerating, premium names in this category continue to command attention.
- Exact-match advantage: The “Med” suffix positions the domain directly in the healthcare space, avoiding ambiguity.
- Investor confidence in .com: Despite rising alternative extensions like .ai and .io, .com remains the gold standard for credibility and global recognition.
The Broker’s Role
According to market sources, the sale was facilitated by domain investor and broker Mike Mann, who has a track record of securing premium valuations for brandable .com names. Mann’s portfolio has produced numerous six- and seven-figure transactions over the past two decades, reinforcing his reputation as one of the industry’s most active high-end sellers.
The VeraMed.com transaction further validates the strategy of patient holding—acquiring premium domains early and waiting for the right end-user buyer willing to pay a strategic price.
The Healthcare Domain Market
Healthcare and life sciences have consistently ranked among the top categories for premium domain sales. In the past year alone, sales of names containing “health,” “care,” and “med” have shown upward momentum, driven by:
- Telehealth adoption post-pandemic.
- Pharmaceutical innovation, particularly around biotech and personalized medicine.
- Digital-first health startups seeking instant recognition and credibility.
For buyers, the investment case is clear: a memorable domain not only aids marketing and search visibility but also instills trust in patients and partners.
Looking Ahead
The sale of VeraMed.com at $167,500 reflects both the resilience of the premium domain market and the enduring appeal of healthcare branding. As investors and companies continue to compete for standout names, sales like this provide benchmarks for what the market is willing to pay for authoritative .coms.
While not as headline-grabbing as seven-figure AI domain deals, VeraMed.com’s sale is a reminder that healthcare remains one of the strongest verticals for premium domain value. With the global digital health industry expected to surpass $650 billion by 2030, names like VeraMed.com will only become more valuable assets in an increasingly crowded market.
